微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | 10.74% | 132.11% | -25.26% | 1/140 | 1.8% | 百利天恒 | 186.1% | 行业排名> |
| 2021-12-31 | 14.37% | 152.89% | 221.06% | 22/140 | 0.09% | 百利天恒 | 186.89% | 行业排名> |
| 2021-09-30 | -11.87% | 36.79% | -28.6% | 124/140 | 4.95% | 百利天恒 | 188.56% | 行业排名> |
| 2021-06-30 | -9.23% | 15.71% | 72.41% | 129/140 | 2.99% | 小方制药 | 41.8% | 行业排名> |
| 2021-03-31 | -33.45% | -137.74% | -23.11% | 121/140 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2020-12-31 | -27.17% | -55.61% | -44.68% | 125/140 | 3.38% | 拓新药业 | 19.87% | 行业排名> |
| 2020-09-30 | -18.78% | -306.37% | -71.51% | 116/140 | 3.49% | 拓新药业 | 19.91% | 行业排名> |
| 2020-06-30 | -10.95% | 49.52% | 22.17% | 123/140 | 4.17% | 小方制药 | 55.57% | 行业排名> |
| 2020-03-31 | -14.07% | -355.35% | 19.42% | 110/140 | 2.15% | 福元医药 | 25.41% | 行业排名> |
| 2019-12-31 | -17.46% | -86.74% | -291.87% | 119/140 | 5.67% | 小方制药 | 34.81% | 行业排名> |
| 2019-09-30 | 9.1% | 177.78% | 141.95% | 44/140 | 7.87% | 退市金泰 | 10.74% | 行业排名> |
| 2019-06-30 | -21.69% | -317.92% | -493.65% | 111/140 | 4.92% | 人福医药 | 6.82% | 行业排名> |
| 2019-03-31 | 5.51% | 252.21% | 158.93% | 12/140 | 2.59% | 小方制药 | 71.99% | 行业排名> |
| 2018-12-31 | -9.35% | -185.06% | 20.09% | 118/140 | 9.03% | 汇宇制药 | 39.25% | 行业排名> |
| 2018-09-30 | -11.7% | -83.39% | -125.43% | 101/140 | 7.74% | 汇宇制药 | 28.14% | 行业排名> |
| 2018-06-30 | -5.19% | -489.77% | -43.37% | 104/140 | 4.99% | 哈三联 | 27.17% | 行业排名> |
| 2018-03-31 | -3.62% | -17.15% | -10.37% | 99/140 | 2.73% | 汇宇制药 | 55.94% | 行业排名> |
| 2017-12-31 | -3.28% | -139.66% | 48.59% | 121/140 | 9.93% | 河化股份 | 45.32% | 行业排名> |
| 2017-09-30 | -6.38% | -355.2% | -625% | 98/140 | 8.45% | 汇宇制药 | 31.9% | 行业排名> |
| 2017-06-30 | -0.88% | -112.12% | 71.52% | 102/140 | 5.33% | 誉衡药业 | 35.56% | 行业排名> |
| 2017-03-31 | -3.09% | -255.17% | -137.36% | 89/140 | 2.15% | 奥赛康 | 35% | 行业排名> |
| 2016-12-31 | 8.27% | -47.09% | 230.8% | 67/140 | 12.26% | 奥赛康 | 28.15% | 行业排名> |
| 2016-09-30 | 2.5% | 142.52% | -65.56% | 70/140 | 8.06% | 宏源药业 | 21.91% | 行业排名> |
| 2016-06-30 | 7.26% | 1130.51% | 934.48% | 27/140 | 5.11% | 奥赛康 | 9.7% | 行业排名> |
| 2016-03-31 | -0.87% | -138.16% | -105.57% | 79/140 | 2.35% | 奥赛康 | 40.69% | 行业排名> |
| 2015-12-31 | 15.63% | -83.95% | 365.82% | 36/140 | 12.01% | 信立泰 | 25.93% | 行业排名> |
| 2015-09-30 | -5.88% | -112.45% | -1096.61% | 78/140 | 7.27% | 昂利康 | 15.91% | 行业排名> |
| 2015-06-30 | 0.59% | -98.87% | -74.12% | 71/140 | 5.27% | 奥赛康 | 12.08% | 行业排名> |
| 2015-03-31 | 2.28% | -89.37% | -97.66% | 34/140 | 2.47% | 一品红 | 31.62% | 行业排名> |
| 2014-12-31 | 97.4% | 2% | 106.18% | 1/140 | 13.28% | 丽珠集团 | 49.43% | 行业排名> |
| 2014-09-30 | 47.24% | 2% | -9.69% | 1/140 | 7.74% | 河化股份 | 54.24% | 行业排名> |
| 2014-06-30 | 52.31% | 2% | 143.87% | 1/140 | -4.04% | 华东医药 | 7.2% | 行业排名> |
| 2014-03-31 | 21.45% | 2% | 2% | 1/140 | 2.5% | 南新制药 | 81.7% | 行业排名> |